Inicio › Linfoma de Burkitt › Georgia › Atlanta
Ensayos clínicos de Linfoma de Burkitt en Atlanta, GA
12 estudios para Linfoma de Burkitt buscan participantes en centros de Atlanta y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
ReclutandoFase 3
- Emory University Hospital/Winship Cancer Institute, Atlanta
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ReclutandoEstudio observacional
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
ReclutandoFase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
ReclutandoFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 1
- Winship Cancer Institute Emory University, Atlanta
- Northside Hospital Cancer Institute, Atlanta
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
ReclutandoFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ReclutandoFase 1/2
- Research Site, Atlanta
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ReclutandoFase 2
- Children's Healthcare of Atlanta at Egleston, Atlanta
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
ReclutandoFase 1
- Winship Cancer Institute, Emory University, Atlanta
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
ReclutandoFase 2
- Children's Healthcare of Atlanta, Atlanta
Ensayos de Linfoma de Burkitt en otras ciudades
- Houston, TX21 estudios
- Philadelphia, PA16 estudios
- Milwaukee, WI16 estudios
- Chicago, IL15 estudios
- New York City, NY13 estudios
- Cincinnati, OH13 estudios
- Aurora, CO11 estudios
- Seattle, WA11 estudios
- Durham, NC10 estudios
- Kansas City, MO10 estudios
- Boston, MA10 estudios
- Los Angeles, CA10 estudios
Otros estudios en Atlanta
- Cáncer (todos los tipos)49 estudios
- Cáncer de pulmón de células no pequeñas47 estudios
- Mieloma múltiple42 estudios
- Cáncer de seno41 estudios
- Cáncer de próstata33 estudios
- Leucemia mielógena aguda31 estudios
- Cáncer de ovario29 estudios
- Cáncer del colon y del recto29 estudios
- Cáncer de pulmón29 estudios
- Cáncer metastásico28 estudios
- Trastorno depresivo mayor25 estudios
- Fallo cardíaco25 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.